CPG Sec. 335.300 Hypnotherapy Devices - Self-Hypnotic Tape Recordings January 1900

COMPLIANCE POLICY GUIDE (CPG)

• Issued by: Office of Regulatory Affairs; Center for Devices and Radiological Health

This compliance policy guide provides guidance to FDA staff on the submission of regulatory action recommendations for self-hypnotic tape recordings which are misbranded.

---

Submit Comments

Submit comments on this guidance document electronically via docket ID: FDA-2013-S-0610 - Specific Electronic Submissions Intended For FDA's Dockets Management Staff (i.e., Citizen Petitions, Draft Proposed Guidance Documents, Variances, and other administrative record submissions)

If unable to submit comments online, please mail written comments to:

Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852

All comments should be identified with the title of the guidance.